2025 (6) TMI 842 - AT - Central Excise

Physician Sample Valuation: Job Work Samples Exempt from Excise Duty Under Rule 8 and Rule 11

The SC examined the valuation of physician samples in a central excise duty dispute. The court ruled in favor of the appellants, holding that samples ... Levy of Central Excise Duty - physician sample sent by the appellants’ as a job worker to the principal manufacturer - HELD THAT:- The issue, whether the physician sample sent by the appellants’ as a job worker to the principal manufacturer should be leviable to the Central Excise duty under Rule 4 ibid read with Section 4A ibid, is no more res integra in view of various judgements delivered by the judicial forum. Reliance can be placed in COMMISSIONER OF CENTRAL EXCISE, GOA VERSUS COSME REMEDIES LTD. AND VICA-VERSA [2016 (4) TMI 323 - CESTAT MUMBAI] where it was held that the valuation of physician samples sold by CRL to Cosme Farma Laboratories should be based on the transaction value under Section 4(1)(a) of the Central Excise Act, and not under Rule 4 of the Central Excise Valuation Rules. Conclusion - Where physician samples are manufactured on job work basis and cleared to the principal manufacturer on payment of duty at transaction value (cost of raw materials plus job charges), valuation under Rule 8 and Rule 11 is appropriate and the department cannot demand duty based on Rule 4 and Section 4A. The adjudged demands confirmed on the appellants cannot be sustained for judicial scrutiny. Therefore, the impugned order is set aside - appeal allowed. The core legal questions considered in this appeal revolve around the proper valuation and levy of Central Excise duty on physician samples manufactured and cleared by the appellants under a job work arrangement. Specifically, the issues are:1. Whether the valuation of physician samples manufactured on a job work basis and sent to the principal manufacturer should be determined under Rule 8 read with Rule 11 of the Central Excise Valuation (Determination of Price of Excisable Goods) Rules, 2000, or under Rule 4 of the said Rules read with Section 4A of the Central Excise Act, 1944.2. Whether the department's demand for Central Excise duty, interest, and penalties based on valuation under Rule 4 and Section 4A is sustainable.Issue-wise detailed analysis:Issue 1: Appropriate Valuation Method for Physician Samples Manufactured on Job Work BasisThe legal framework involves the Central Excise Valuation (Determination of Price of Excisable Goods) Rules, 2000, primarily Rule 4 (transaction value method), Rule 8 (valuation of goods manufactured on job work basis), and Rule 11 (determination of assessable value in certain cases), along with Section 4A of the Central Excise Act, 1944, which provides for valuation on the basis of Maximum Retail Price (MRP) less abatement.The department contended that valuation should be under Rule 4 read with Section 4A, implying that physician samples should be valued on MRP basis less abatement, as they are distributed free of cost. The appellants, however, adopted valuation under Rule 8 read with Rule 11, calculating assessable value as cost of raw materials plus job charges.The Court examined precedents, notably:Commissioner of Central Excise, Goa Vs. Cosme Remedies Ltd. (2016) - Tribunal held that physician samples manufactured on job work basis and cleared to the principal manufacturer on payment of duty at transaction value (cost of raw materials plus job charges) are not liable to be valued under Rule 4 read with Section 4A.Omni Protech Drugs Pvt. Ltd. Vs. Commissioner of Central Excise, Pune-I (2011) - The Tribunal distinguished cases where manufacturers distribute physician samples free of cost (valuation under Section 4A) from cases where samples are cleared on payment of duty on transaction value basis.Commissioner of Central Excise & Customs, Surat Vs. Sun Pharmaceuticals Industries Ltd. (2015) and subsequent Supreme Court rulings - These judgments reinforced the principle that valuation depends on the nature of the transaction and the relationship between the job worker and principal manufacturer.The Tribunal in Cosme Remedies Ltd. emphasized that when physician samples are cleared by the job worker to the principal manufacturer on a principal-to-principal basis and duty is paid on transaction value, the valuation under Rule 8 and Rule 11 is appropriate. The department's reliance on Rule 4 and Section 4A was found misplaced in such factual matrix.The Court reasoned that the department's contention ignored the fundamental distinction between samples distributed free of cost to physicians (where no transaction value exists) and samples cleared to the principal manufacturer on payment of duty. The former scenario justifies valuation on MRP less abatement under Section 4A, while the latter permits valuation based on cost plus job charges under Rule 8 and Rule 11.The Court applied this legal framework to the facts, noting that the appellants manufactured physician samples on job work basis and cleared them to the principal manufacturer on payment of duty calculated on cost plus job charges. The department's demand based on Rule 4 and Section 4A was therefore unsustainable.Competing arguments from the department, which relied on the statutory provision for valuation under Section 4A and Rule 4, were rejected on the ground that these provisions are applicable only where goods are cleared without a transaction value, such as free distribution to physicians. The appellants' case involved a transaction value and a principal-to-principal relationship, which the judicial precedents clearly support as warranting valuation under Rule 8 and Rule 11.Issue 2: Sustenance of Demand for Duty, Interest, and PenaltyThe department initiated show cause proceedings and adjudicated a duty demand of Rs. 15,89,112 along with interest and imposed penalties under Section 11AC of the Central Excise Act and Rule 25 of the Central Excise Rules, 2002. The Commissioner (Appeals) upheld these demands.Given the legal position established in the precedents and the factual matrix of the case, the Court found that the demand confirmed by the adjudicating authority and Commissioner (Appeals) lacked legal basis. The Court observed that since the valuation method adopted by the appellants was correct and in line with binding judicial decisions, the demand of duty, interest, and penalty could not be sustained.The Court did not delve into the issue of limitation or other procedural defenses as the substantive legal issue of valuation was dispositive.Significant holdings:'In view of the fact that the issue arising out of the present dispute is no more open for any debate, in view of the authoritative judgement delivered by the judicial forum, we are of the considered opinion that the adjudged demands confirmed on the appellants cannot be sustained for judicial scrutiny.''Therefore, the impugned order is set aside and the appeal is allowed in favour of the appellants.'The Court reaffirmed the principle that where physician samples are manufactured on job work basis and cleared to the principal manufacturer on payment of duty at transaction value (cost of raw materials plus job charges), valuation under Rule 8 and Rule 11 is appropriate and the department cannot demand duty based on Rule 4 and Section 4A.In conclusion, the Court allowed the appeal, set aside the impugned order confirming duty demand and penalties, and directed incorporation of the correct party names in the appeal records as per the miscellaneous application.